Saneca Pharma has announced the appointment of a new CDMO sales director. Markus Saal joins the senior team and brings along nearly 30 years’ experience in the industry. His main responsibilities will involve heading up the company’s finished dosage form (FDF) sales and business development activity. 

Anthony Sheehan, chief executive officer at Saneca Pharma, said, “We’re delighted to welcome Markus to the team to drive our plans forward. Having worked across Europe, the US, the Middle East and Asia, Markus brings a wealth of industry knowledge and experience to the CDMO as it prepares for its next phase of growth.”

Saneca Pharma provides customers with capabilities in solids, semi-solids and liquids, as well as specialist expertise in the development and manufacture of APIs and finished dosage forms from farm to pharmacy.